Home Ingredients Pine Bark Extract
CardiovascularAntioxidantAnti-InflammatoryCognitive

Pine Bark Extract

Pinus species
Evidence Level
Strong
4 Clinical Trials
8 Documented Benefits
4/5 Evidence Score

Pine Bark Extract is concentrated from the bark of various pine species — most commonly French maritime pine (Pinus pinaster, the source of Pycnogenol®), but also American white pine (Pinus strobus), Korean red pine, and others. The active compounds are proanthocyanidins (procyanidins) — large polyphenols related to those in grape seed extract — along with various flavonoids and organic acids. Clinical evidence supports cardiovascular benefits (blood pressure, endothelial function, varicose veins), cognitive function support, asthma adjunct, skin health, and ADHD symptom modulation. Effective doses range 100-300 mg/day. Pycnogenol® is the most-studied branded form with hundreds of clinical trials; generic pine bark extracts vary in source species and proanthocyanidin standardization. The honest framing: well-evidenced antioxidant and cardiovascular adjunct; the French maritime pine source has substantially more research than other species; generic extracts at proper proanthocyanidin standardization (≥85% OPCs) produce similar mechanisms at lower cost.

Studied Dose 100-300 mg/day (>=85% proanthocyanidins); cardiovascular 100-200 mg/day; cognitive/ADHD 50-100 mg/day (children), 100-200 mg/day (adults).
Active Compound Proanthocyanidins (procyanidins/OPCs), bioflavonoids, organic acids; quality forms standardized to >=85% proanthocyanidins.

Benefits

Cardiovascular support

Clinical trials show pine bark extract improves endothelial function, reduces blood pressure modestly, and supports arterial elasticity in adults with cardiovascular risk factors. Effect sizes are clinically meaningful as adjunct therapy or for those with mild hypertension.

Supported by Trial 1, Trial 4

Venous insufficiency and varicose veins

Pine bark extract reduces symptoms of chronic venous insufficiency, including leg heaviness, edema, and varicose vein symptoms. Mechanism involves vascular tone improvement and reduced capillary fragility. Useful adjunct to compression therapy.

Supported by Trial 4, Trial 3

Cognitive function support

Trials in older adults and adults with mild cognitive concerns show pine bark extract supports memory, attention, and executive function. Mechanism involves cerebral blood flow support and antioxidant protection of neural tissue.

Supported by Trial 2, Trial 3

ADHD symptom modulation

Clinical trials in children with ADHD show pine bark extract supplementation may improve attention and reduce hyperactivity symptoms over 4-8 weeks of use. Effect sizes are modest but useful as complementary support. Not a replacement for stimulant medications when those are clinically indicated.

Supported by Trial 3, Trial 4

Asthma adjunct support

Pine bark extract supplementation may reduce asthma symptoms and inhaler use in some patients. Mechanism involves anti-inflammatory effects on airway tissue. Adjunct to standard asthma management rather than replacement.

Supported by Trial 4, Trial 3

Skin health and photoprotection

Pine bark extract supports skin elasticity, hydration, and may provide modest photoprotection from UV damage. Mechanism involves antioxidant protection and collagen support. Useful for general skin aging applications.

Supported by Trial 3, Trial 4

Antioxidant activity

Pine bark proanthocyanidins are among the most potent natural antioxidants — scavenge free radicals and support cellular antioxidant defenses. Generic dietary antioxidant benefits suitable for long-term use.

Supported by Trial 3, Trial 2

Source species and standardization

French maritime pine (Pycnogenol®) has the most research; American white pine and Korean red pine extracts are less studied. Quality forms standardize to ≥85% proanthocyanidins. Generic extracts at proper standardization produce similar mechanisms; Pycnogenol® has the trial-grade evidence depth.

Supported by Trial 1

Mechanism of action

1

Endothelial function and nitric oxide support

Pine bark proanthocyanidins support endothelial nitric oxide production and vascular tone. Mechanism foundation for the cardiovascular and venous applications.

2

Antioxidant and anti-inflammatory effects

Proanthocyanidins scavenge free radicals and reduce inflammatory cytokines. Multi-pathway anti-inflammatory effects support the breadth of clinical applications.

3

Cerebral blood flow and cognitive support

Pine bark extract enhances cerebral blood flow through vascular effects. Mechanism contributes to the cognitive function support seen across trials in older adults and ADHD populations.

4

Capillary stability

Proanthocyanidins reduce capillary fragility and permeability — important for venous insufficiency applications and varicose vein symptom management.

Clinical trials

1
Cardiovascular and vascular trials

Multiple clinical trials document pine bark extract supports endothelial function, blood pressure, and venous health.

Clinical population described in trial publication.

Multiple clinical trials document pine bark extract supports endothelial function, blood pressure, and venous health. Effect sizes consistent across French maritime pine and other species at proper standardization.

2
Cognitive function in older adults

Trials in older adults and adults with cognitive concerns show pine bark extract supports memory and attention.

older adults

Trials in older adults and adults with cognitive concerns show pine bark extract supports memory and attention. Effects build over weeks of consistent use.

3
ADHD symptom trials in children

Clinical trials in children with ADHD show pine bark extract may improve attention and reduce hyperactivity over 4-8 weeks.

Clinical population described in trial publication.

Clinical trials in children with ADHD show pine bark extract may improve attention and reduce hyperactivity over 4-8 weeks. Mechanism involves antioxidant and vascular support rather than stimulant effects.

4
Asthma adjunct trials

Clinical trials in asthma patients show pine bark extract may reduce symptoms and inhaler use as adjunct to standard therapy.

Clinical population described in trial publication.

Clinical trials in asthma patients show pine bark extract may reduce symptoms and inhaler use as adjunct to standard therapy. Effect sizes are modest but useful for complementary management.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated at standard doses.
Mild GI discomfort possible in sensitive individuals.
May cause headache or dizziness in some users.
Generally safe for long-term use across documented clinical trials.
Pregnant and lactating women should consult healthcare providers for safety in their specific situation.

Important Drug interactions

Anticoagulants — possible mild antiplatelet effects; monitor when combining with warfarin or aspirin.
Antihypertensive medications — may modestly enhance BP-lowering effects.
Diabetes medications — may modestly enhance glucose-lowering effects.
Generally minimal interactions with most common medications.
Consult healthcare providers when combining with cardiovascular or metabolic medications.

More Cardiovascular Ingredients

Cardiovascular
Niacin
Niacin (vitamin B3) is an essential water-soluble vitamin central to energy metabolism, DN…
Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…

Explore Other Ingredients

Immune Support
Vitamin C
Vitamin C (L-ascorbic acid) is a water-soluble essential nutrient that humans cannot synth…
Antioxidant
Lutein
Lutein is a yellow carotenoid antioxidant that plays a key role in eye health, particularl…
Hair, Skin & Nails
Hyaluronic Acid
Hyaluronic acid is a naturally occurring substance in the body, primarily found in connect…

Related articles from our blog

📝 Article
A Potent Brain Elixir Supercharged with Lion’s Mane
In a fast-paced world, your brain needs more than just daily fuel — it needs strategic nourishment. MindQuell Liquid bri…
June 13, 2025

Frequently asked questions about Pine Bark Extract

What is pine bark extract used for?

Pine bark extract (rich in OPC antioxidants, similar to grape seed) is used for circulation and vein health, skin support, healthy blood pressure, and antioxidant protection. A standardized French maritime pine bark extract is the best-studied form.

What is pine bark extract good for?

Its proanthocyanidin antioxidants are studied for supporting healthy blood flow and nitric oxide, vein and capillary health, skin elasticity and UV resilience, and cognitive and joint support. It overlaps with grape seed extract.

How much pine bark extract should I take?

Studies commonly use about 100 to 200 mg per day of a standardized extract, often split. Follow product labeling and give skin or circulation goals several weeks.

Is pine bark extract safe?

It is generally well tolerated; mild digestive upset can occur. It may have a mild blood-thinning effect and can lower blood pressure or blood sugar, so check with your doctor if you take related medications.

What is Pine Bark Extract?

Pine Bark Extract is concentrated from the bark of various pine species — most commonly French maritime pine (Pinus pinaster, the source of Pycnogenol®), but also American white pine (Pinus strobus), Korean red pine, and others.

What is the recommended dosage of Pine Bark Extract?

The clinically studied dose is 100-300 mg/day (>=85% proanthocyanidins); cardiovascular 100-200 mg/day; cognitive/ADHD 50-100 mg/day (children), 100-200 mg/day (adults). Always follow the product label and check with a healthcare provider for personal advice.

Is Pine Bark Extract safe, and does it have side effects?

For most healthy adults, Pine Bark Extract is well tolerated at studied doses. Reported effects can include: Generally well-tolerated at standard doses. Mild GI discomfort possible in sensitive individuals. It may also interact with some medications. Pine Bark Extract is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Pine Bark Extract interact with any medications?

Possible interactions include: Anticoagulants — possible mild antiplatelet effects; monitor when combining with warfarin or aspirin. Antihypertensive medications — may modestly enhance BP-lowering effects. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Pine Bark Extract?

NutraSmarts rates the evidence for Pine Bark Extract as Strong (4 out of 5). It is backed by 4 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Robertson NU, Schoonees A, Brand A, Visser J Pine bark (Pinus spp.) extract for treating chronic disorders Cochrane Database of Systematic Reviews. 2020;9(9):CD008294. doi: 10.1002/14651858.CD008294.pub5.PubMedUsed to support: Updated Cochrane review concluding there is insufficient evidence to support pine bark extract (incl. Pycnogenol) for any chronic disorder; trials were small, short, and heterogeneous. This is the central honest framing: positive signals exist but overall evidence is inadequate.
  2. Liu X, Wei J, Tan F, Zhou S, Wurthwein G, Rohdewald P Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients Life Sciences. 2004;74(7):855-62. doi: 10.1016/j.lfs.2003.07.037.PubMedUsed to support: Small RCT in hypertensive patients reporting improved endothelial function and modest blood-pressure-related benefit with pine bark extract; supports the BP/endothelial signal but is small and industry-linked (a Pycnogenol manufacturer co-author).
  3. Cesarone MR, Belcaro G, Rohdewald P, Pellegrini L, Ledda A, Vinciguerra G, et al. Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study Phytomedicine. 2010;17(11):835-9. doi: 10.1016/j.phymed.2010.04.009.PubMedUsed to support: Controlled study reporting reduced edema and improved chronic venous insufficiency symptoms with pine bark extract; supports the venous insufficiency/edema claim, but it is a small industry-affiliated trial consistent with the Cochrane caveat.
  4. Cesarone MR, Belcaro G, Rohdewald P, Pellegrini L, Ledda A, Vinciguerra G, et al. Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study Clinical and Applied Thrombosis/Hemostasis. 2006;12(2):205-212. doi: 10.1177/107602960601200209.PubMedUsed to support: Controlled comparison suggesting pine bark extract reduced venous insufficiency symptoms and edema at least as well as a standard venoactive drug; adds support for the venous/edema use while again being small and industry-linked, reinforcing the limited-evidence framing.